NDC 0781-2793 – Mesalamine
Mesalamine 500 mg/1 · Capsule, Extended Release · Oral
Product NDC0781-2793
Product details
- Brand name
- Mesalamine
- Generic name
- Mesalamine
- Labeler
- Sandoz Inc
- Dosage form
- Capsule, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA219997
- Marketed since
- July 15, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Aminosalicylate
Active ingredients
- Mesalamine 500 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0781-2793-72 | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0781-2793-72) | Jul 15, 2026 |
Other Mesalamine products
- 62332-724 Mesalamine .375 g/1 · Capsule, Extended Release · Alembic Pharmaceuticals Inc.
- 46708-724 Mesalamine .375 g/1 · Capsule, Extended Release · Alembic Pharmaceuticals Limited
- 60687-650 Mesalamine .375 g/1 · Capsule, Extended Release · American Health Packaging
- 67877-717 Mesalamine .375 g/1 · Capsule, Extended Release · Ascend Laboratories, LLC
- 59651-397 Mesalamine .375 g/1 · Capsule, Extended Release · Aurobindo Pharma Limited
- 50268-577 Mesalamine .375 g/1 · Capsule, Extended Release · AvPAK
- 31722-489 Mesalamine 375 mg/1 · Capsule, Extended Release · Camber Pharmaceuticals, Inc.
- 51407-976 Mesalamine .375 g/1 · Capsule, Extended Release · Golden State Medical Supply, Inc.
- 50742-371 Mesalamine .375 g/1 · Capsule, Extended Release · Ingenus Pharmaceuticals, LLC
- 0378-1375 Mesalamine .375 g/1 · Capsule, Extended Release · Mylan Pharmaceuticals Inc.
- 68682-113 Mesalamine 375 mg/1 · Capsule, Extended Release · Oceanside Pharmaceuticals
- 0781-2791 Mesalamine 250 mg/1 · Capsule, Extended Release · Sandoz Inc